Clinical Trial Update: Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial update on GSK3772847 for moderately severe asthma, reporting efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK3772847

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2020-03-02